Tag Archives: Alzheimer’s Disease

Women’s Aging Brains: Study finds adult female brain is on average a few years younger than the male brain. And new link found between menopause and far greater incidence of Alzheimer’s among women.

      No Comments on Women’s Aging Brains: Study finds adult female brain is on average a few years younger than the male brain. And new link found between menopause and far greater incidence of Alzheimer’s among women.

The News: Possibly to the chagrin of some men, a new study finds that women tend to have more youthful brains than their male counterparts–at least when it comes to… Read more »

Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

      No Comments on Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo, Labiotech.eu reports. The… Read more »

Atrial fibrillation increases risk of dementia by 40%, Swedish study shows. Bring on those blood thinners, say researchers.

      No Comments on Atrial fibrillation increases risk of dementia by 40%, Swedish study shows. Bring on those blood thinners, say researchers.

The News: New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. An irregular heartbeat speeds up the… Read more »

Researchers say autobiographical memory test may foretell Alzheimer’s risk. Study invokes friends, relatives and sparks uneasy self-reflection.

      No Comments on Researchers say autobiographical memory test may foretell Alzheimer’s risk. Study invokes friends, relatives and sparks uneasy self-reflection.

The News: Testing how well people remember past events in their lives could help medical professionals make early predictions about who is at risk for developing Alzheimer’s disease (AD), according… Read more »

Forget about Biogen/Eisai’s promising new drug for Alzheimer’s; Study says aggressive blood-pressure treatment with existing meds reduces dementia/AD risk.

      No Comments on Forget about Biogen/Eisai’s promising new drug for Alzheimer’s; Study says aggressive blood-pressure treatment with existing meds reduces dementia/AD risk.

The News: After decades of prominent failures, hope arose for a drug to slow the progression of Alzheimer’s disease (AD). After heightening expectations recently, Eisai Co. Ltd. (Tokyo) and Biogen… Read more »

Tiny Swedish biotech not taking back seat to US in Alzheimer’s race. How to buy it.

      No Comments on Tiny Swedish biotech not taking back seat to US in Alzheimer’s race. How to buy it.

The News: BioArctic AB, based in Stockholm, said it has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial… Read more »

Links between Alzheimer’s disease and viruses are building. But decades of soul-crushing frustration for patients and scientists suggest that this latest finding might go the way of its forerunners.

      No Comments on Links between Alzheimer’s disease and viruses are building. But decades of soul-crushing frustration for patients and scientists suggest that this latest finding might go the way of its forerunners.

The News: It has long been a controversial theory about Alzheimer’s disease (AD), often dismissed by experts as a random detour from mainstream research. But a new study by a team that… Read more »

Investors pour $76 million into B round for Cortexyme’s “new” approach to Alzheimer’s. No, it doesn’t target Amyloid beta (Aβ); it’s bacterial and getting support from Pfizer, Paul Allen.

      No Comments on Investors pour $76 million into B round for Cortexyme’s “new” approach to Alzheimer’s. No, it doesn’t target Amyloid beta (Aβ); it’s bacterial and getting support from Pfizer, Paul Allen.

The News: With the evidence increasingly weighing in against amyloid beta as the best solo target for Alzheimer’s, startup Cortexyme Inc. (South San Francisco) has identified a brand-new target and… Read more »

New advance directives permit dementia patients to refuse eating — no matter what — thereby nullifying the competence conundrum and avoiding “unwanted care.” About time.

      No Comments on New advance directives permit dementia patients to refuse eating — no matter what — thereby nullifying the competence conundrum and avoiding “unwanted care.” About time.

The News: Stepping into ethically and legally uncertain territory, a New York end-of-life agency has approved a new document that lets people stipulate in advance that they don’t want food… Read more »

Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’s symptoms. Now what?

      No Comments on Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’s symptoms. Now what?

The News: Long-term consumption of caffeine would worsen the neuropsychiatric symptoms of people with Alzheimer’s disease, according to a study on mice, published in Frontiers in Pharmacology. So far, many studies… Read more »